Fundraising Fox

Sensible Biotechnologies

YC S21 ↗

Oxford, GB · Founded 2021 · 24 employees · 6 known investors

sensible.bio ↗

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.

AI & Machine LearningBiotechDeep TechHealthtechSynthetic BiologyManufacturingTherapeuticsBiotechnologyin /sensible-biotechnologies/@sensible_bioycombinator.com ↗

Founders & leadership· Y Combinator alumni (S21)

MGMiroslav Gasparek
Miroslav Gasparekin𝕏Founder
MKMarian Kupculak
Marian KupculakinFounder

Investors · 6

Civilization Ventures Management, LlcTiburon · $1M – $10M
KAYAPrague · $108K – $3.2M
Recode VenturesSan Franciscovia Armen A. Vidian · inferred
Y CombinatorSan Francisco · $500K
ZAKA VCSan Francisco
BlueYard Capitalreported · 2 sourcesBerlin · $500K – $5M

Reported raises · per SEC filings

Form D private placements
▶$1.8MraisedFeb 2023 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marian KupculakExecutive Officer, Director
  • Miroslav GasparekExecutive Officer, Director
Offering amount
$3M
Amount sold
$1.8M
Proceeds to insiders
$100K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Companies House · registry record

View on Companies House ↗
Registered name
SENSIBLE BIOTECHNOLOGIES LIMITED
Company number
14628427
Status
Active
Company type
Private limited company
Incorporated
31 Jan 2023
Registered office
3rd Floor 1 Ashley Road, Altrincham, Cheshire, WA14 2DT
Nature of business (SIC)
72110 — Research and experimental development on biotechnology72190 — Other research and experimental development on natural sciences and engineering
Accounts
last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement
last made up to 30 Jan 2026 · next due 13 Feb 2027

Current officers · 2

  • Miroslav Gasparek — director, appointed 31 Jan 2023
  • Marian Kupculak — director, appointed 31 Jan 2023

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news